The results showed that the plasma exosomal Aβ42, Aβ42/40, Tau, and P‐T181‐tau levels of the aMCI and AD groups were significantly higher than those of the SCD group, control group, and VaD group, and those of the AD group were higher than those of the aMCI group. The gene discussed is MAPT; the disease is Alzheimer disease.